Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Indometacin 15mg/5ml oral liquid
1001010K0AAAZAZ
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 20mg/5ml oral liquid
1001010K0AAARAR
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 25mg modified-release capsules
1001010K0AAACAC
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 25mg modified-release tablets
1001010K0AAALAL
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 25mg/5ml oral suspension sugar free
1001010K0AAAEAE
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 31.25mg/5ml oral liquid
1001010K0AAAWAW
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 3mg/5ml oral liquid
1001010K0AAASAS
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 500micrograms/5ml oral liquid
1001010K0AAAUAU
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 50mg modified-release tablets
1001010K0AAAKAK
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 50mg/5ml oral liquid
1001010K0AAAVAV
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indomod 25mg modified-release capsules
1001010K0BIAAAC
|
Indomod | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indomod 75mg modified-release capsules
1001010K0BIABAD
|
Indomod | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Inflectra 100mg pdr for concentrate for inf vials
1001030T0BDAAAA
|
Inflectra | Infliximab | Musculoskeletal and Joint Diseases | No data available |
|
Infliximab 100mg powder for solution for infusion vials
1001030T0AAAAAA
|
Infliximab | Infliximab | Musculoskeletal and Joint Diseases | No data available |
|
Infliximab 120mg/1ml inj pre-filled disposable devices
1001030T0AAABAB
|
Infliximab | Infliximab | Musculoskeletal and Joint Diseases | No data available |
|
Infliximab 120mg/1ml inj pre-filled syringes
1001030T0AAACAC
|
Infliximab | Infliximab | Musculoskeletal and Joint Diseases | No data available |
|
Intralgin gel
100302000BBBBAA
|
Proprietary compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | No data available |
|
Joint-Flex Daily 750mg tablets
1001050A0BCAAAB
|
Joint-Flex Daily (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Jomethid XL 200mg capsules
1001010L0BMAAAJ
|
Jomethid | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Junior Ibuprofen 100mg/5ml oral suspension
1001010J0CDABBH
|
Numark Ibuprofen (Systemic) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Jylamvo 2mg/ml oral solution
1001030U0BHAACF
|
Jylamvo | Methotrexate | Musculoskeletal and Joint Diseases | No data available |
|
Jyseleca 100mg tablets
1001030AGBBAAAA
|
Jyseleca | Filgotinib | Musculoskeletal and Joint Diseases | No data available |
|
Jyseleca 200mg tablets
1001030AGBBABAB
|
Jyseleca | Filgotinib | Musculoskeletal and Joint Diseases | No data available |
|
Kaolin poultice 100g pouches
1003020L0AAACAC
|
Kaolin heavy | Kaolin heavy | Musculoskeletal and Joint Diseases | No data available |
|
Ketocid 200 modified-release capsules
1001010L0BIAAAJ
|
Ketocid 200 | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.